Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

  • Etude concernée: MAPS
  • Auteurs / Authors: Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Rivière F, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti JJ, Scherpereel A
  • Journal / Conference: The Lancet
  • Année / Year: 2016
  • PMID: 26719230
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/26719230/
  • PDF: MAPS.Lancet.12.2015.pdf